1 Min Read
Jan 8 (Reuters) - Cipher Pharmaceuticals Inc:
* CIPHER PHARMACEUTICALS ANNOUNCES CANADIAN LAUNCH OF OZANEX™ (OZENOXACIN CREAM 1%), A NOVEL TOPICAL ANTIBIOTIC Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.